Vasundhara Rasayans share news, announcements and annual reports
BSE: 538634Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 30 Oct 2026. Previous close ₹140.60.
30 Oct: open ₹132.20, high ₹132.20, low ₹130.00
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹41 Cr3,534th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 7.00
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.01
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 1.54%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 15.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 13.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.04
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 316
Vasundhara Rasayans share news and announcements
427 announcements, routine notices left out, newest first. Page 2 of 9.
Nov 2024
14 Nov · Announcement under Regulation 30 (LODR)-Change in Corporate Office Address
5 Nov · Board meeting
Meeting on 14 Nov 2024: quarterly results
Oct 2024
Sep 2024
8 Sep · Corporate action
7 Sep · Board meeting
4 Sep · Board meeting
Meeting on 7 Sep 2024: annual general meeting and final dividend
Aug 2024
14 Aug · Board meeting
14 Aug · Results
7 Aug · Board meeting
Meeting on 14 Aug 2024: quarterly results
Jul 2024
11 Jul · CURRENT MOVEMENTS IN SHARE PRICE OF THE COMPANY
8 Jul · Legal
Exchange has sought clarification from Vasundhara Rasayans Ltd on July 8, 2024 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
May 2024
21 May · Board meeting
Meeting on 28 May 2024: audited results
Apr 2024
15 Apr · Submission Of Compliance Certificate As Per Regulation 7(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For Year Ended March 31St, 2024.
15 Apr · Submission Of Certificate As Per Regulation 40(9) Of SEBI Listing Regulations 2015.
Feb 2024
12 Feb · Board meeting
5 Feb · Board meeting
Meeting on 12 Feb 2024: quarterly results
Dec 2023
Nov 2023
2 Nov · Board meeting
Meeting on 10 Nov 2023: quarterly results
Aug 2023
14 Aug · Results
14 Aug · Results
8 Aug · Board meeting
Meeting on 14 Aug 2023: quarterly results